| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.68B | $4.47B | $4.33B |
| YoY Revenue Growth % | +4.7% | +3.2% | — |
| Gross Profit | $4.59B | $4.39B | — |
| Gross Margin % | 98.0% | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $364.4M | $324.5M | $314.0M |
| Operating Margin % | 7.8% | 7.3% | 7.2% |
| Net Income (GAAP) | $212.1M | $148.8M | $181.3M |
| EBITDA (Normalized) | $589.5M | $586.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $296.3M | $266.8M | $382.0M |
| Capital Expenditures (CapEx) | $281.4M | $327.6M | — |
| Free Cash Flow (FCF) | $15.0M | -$60.8M | $382.0M |
| FCF Margin % | 0.3% | -1.4% | 8.8% |
| Return on Invested Capital (ROIC %) | 18.9% | 23.5% | — |
| Cash & Short-Term Equivalents | $373.4M | $135.1M | — |
| Total Debt (Short + Long Term) | $1.13B | $716.0M | — |
| Total Stockholders' Equity | $770.5M | $508.1M | — |